Wikipedia:
Proscillaridin
 |
|
|
Proscillaridin
|
|
| Systematic (IUPAC) name | |
| 3β-Rhamnosido- 14β-hydroxybufa 4, 20, 22 trienolide |
|
| Identifiers | |
| CAS number | |
| ATC code | C01 |
| PubChem | |
| Chemical data | |
| Formula | C30H42O8 |
| Mol. mass | 530.650 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Proscillaridin is a bufanolide glycoside, it can be obtained from plants of the genus Scilla.
| Cardiac glycosides (C01A) | |
|---|---|
| Digitalis glycosides | Acetyldigitoxin - Acetyldigoxin - Digitalis leaves - Digitoxin - Digoxin - Lanatoside C - Deslanoside - Metildigoxin - Gitoformate |
| Scilla glycosides | Proscillaridin |
| Strophantus glycosides | G-strophanthin - Cymarin |
| Other cardiac glycosides | Peruvoside |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
